Trexquant Investment LP Taro Pharmaceutical Industries LTD Transaction History

Trexquant Investment LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$40.97 - $43.33 $280,234 - $296,377	6,840 New	6,840 $289,000
Q3 2019 Nov 08, 2019	SELL	$75.36 - $86.57 $297,219 - $341,432	-3,944 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$83.92 - $108.88 $330,980 - $429,422	3,944 New	3,944 $337,000
Q2 2018 Aug 07, 2018	SELL	$97.62 - $120.59 $616,567 - $761,646	-6,316 Closed	0 $0
Q1 2018 May 03, 2018	BUY	$95.91 - $107.26 $150,962 - $168,827	1,574 Added 33.19%	6,316 $624,000
Q4 2017 Feb 09, 2018	BUY	$104.5 - $126.38 $495,539 - $599,293	4,742	4,742 $497,000

16.9K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.